Near-Patient Molecular Solutions Market Envisions a Striking US$7.56 Billion Valuation by 2033
The emphasis on near-patient solutions reflects a commitment to timely interventions and personalized healthcare. Innovations in molecular technologies contribute to the market’s pivotal role in reshaping diagnostic approaches, catering to diverse medical needs, and ultimately improving patient outcomes through efficient and convenient testing at the point of care.